Cancer treatment
Immunotherapy in Acute Myeloid Leukemia Lacks Breakthroughs, Researchers Argue
Current studies on oncology, specifically acute myeloid leukemia, have revealed a significant disparity between the effectiveness of immunotherapy in lymphoid malignancies and its lackluster performance in acute myeloid leukemia. Despite dramatic improvements in outcomes for lymphoid malignancies, such as B cell cancers, AML has not experienced a comparable breakthrough. Researchers